fidoptProstate cancer on biparametric MR, segmentation
0 datasets, 0 test cases. A method is ranked here when it has a result on every case of every one of them.
Read before comparing
- Ranked apart: only clinically significant cancers (ISUP 2 or more) are traced, so a lower-grade or benign lesion a method finds counts against it; two label sets drawn on different grids.
- 1 dataset of this kind is shown below and not ranked on the official board: its licence does not allow a public leaderboard. The research board (Research, above the ranking) ranks it too.
Ranking OfficialResearch
No method has a complete result on any dataset here yet.
1 place in that table, 1 is best2/10 cases done, not ranked yetn/a does not apply not run some cases failed
Under each dataset, the method's place in that dataset's table: 1 is best, the darker the better. The mean rank averages its places over the datasets.